Kamala Hospital and Research Centre (TSCS), Hyderabad, — was selected as one of the two TIF Collaborating Centres in India

Kamala Hospital and Research Centre for Thalassemia and Sickle Cell Disease, operating under Thalassemia and Sickle Cell Society (TSCS), Hyderabad, has been officially designated as one of the key Thalassaemia International Federation (TIF) Collaborating Centres in India.

This recognition places the facility among a global network of elite centres that are committed to raising the standards of care, education, and research in the field of haemoglobinopathies, including Thalassemia and Sickle Cell Disease (SCD) making it a significant achievement in India’s healthcare landscape.

In the month of Feb 2025, an official on-site evaluation was carried out by an expert delegation comprising Prof. Antonio Piga and Prof. Dimitrios Farmakis. Their inspection included Kamala Hospital & Research Centre (TSCS) in Hyderabad, All India Institute of Medical Sciences (AIIMS), New Delhi, and Post Graduate Institute of Child Health, Noida. Following an in-depth post-visit assessment — Kamala Hospital and Research Centre (TSCS), Hyderabad, — was selected as one of the two TIF Collaborating Centres in India. TIF Collaborating Centres network is a cornerstone initiative designed to close persistent gaps in care, education, and human resources across countries struggling with high burdens of Thalassemia and Sickle Cell Disease.